Geode Capital Management
IMCR icon

Geode Capital Management’s Immunocore IMCR Stock Holding History

Geode Capital Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46M Buy
45,974
+3,092
+7% +$91.5K ﹤0.01% 3263
2026
Q1 		$1.29M Sell
42,882
-144
-0.3% -$4.66K ﹤0.01% 3281
2025
Q4 		$1.49M Sell
43,026
-2,943
-6% -$104K ﹤0.01% 3257
2025
Q3 		$1.67M Sell
45,969
-6,032
-12% -$205K ﹤0.01% 3241
2025
Q2 		$1.63M Buy
52,001
+14,877
+40% +$462K ﹤0.01% 3193
2025
Q1 		$1.1M Buy
37,124
+1,632
+5% +$49K ﹤0.01% 3273
2024
Q4 		$1.05M Buy
35,492
+420
+1% +$13.3K ﹤0.01% 3363
2024
Q3 		$1.09M Sell
35,072
-70
-0.2% -$2.55K ﹤0.01% 3323
2024
Q2 		$1.19M Buy
35,142
+8,097
+30% +$413K ﹤0.01% 3245
2024
Q1 		$1.76M Buy
27,045
+1,016
+4% +$69.7K ﹤0.01% 3164
2023
Q4 		$1.78M Buy
26,029
+1,639
+7% +$85.2K ﹤0.01% 3149
2023
Q3 		$1.27M Buy
24,390
+7,044
+41% +$417K ﹤0.01% 3234
2023
Q2 		$1.04M Buy
17,346
+2,888
+20% +$165K ﹤0.01% 3332
2023
Q1 		$715K Hold
14,458
– – ﹤0.01% 3509
2022
Q4 		$825K Sell
14,458
-2,006
-12% -$113K ﹤0.01% 3445
2022
Q3 		$772K Hold
16,464
– – ﹤0.01% 3523
2022
Q2 		$614K Buy
16,464
+6,989
+74% +$227K ﹤0.01% 3647
2022
Q1 		$283K Buy
9,475
+3,478
+58% +$87.8K ﹤0.01% 4205
2021
Q4 		$205K Hold
5,997
– – ﹤0.01% 4461
2021
Q3 		$222K Hold
5,997
– – ﹤0.01% 4408
2021
Q2 		$234K Buy
+5,997
New +$232K ﹤0.01% 4278

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Geode Capital Management's IMCR Position: Q2 2026 in Review

Geode Capital Management increased its Immunocore (IMCR) stake by 7.2% in Q2 2026, buying an estimated $91.5K and bringing the position to 45,974 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #3263.

Geode Capital Management first reported a position in IMCR in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.78M in Q4 2023. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Geode Capital Management held 45,974 shares of Immunocore worth $1.46M as of Q2 2026.
  • Geode Capital Management bought 3,092 Immunocore shares in Q2 2026, an estimated $91.5K.
  • Immunocore made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3263 holding.
  • Geode Capital Management first reported a position in Immunocore in Q2 2021 and has held it in 21 quarters since.
  • Geode Capital Management's Immunocore position peaked at $1.78M in Q4 2023.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.